Massachusetts attracts scientists and researchers from across the world as a hub of biotech and biomedical research, but funding cuts enacted by the Trump administration, along with severe immigration policies, have changed that attraction to repulsion.

Those same leaders in biomedical research are now relocating or changing careers altogether, searching for funding, stability and safety.

The Globe partnered with MassInc. Polling Group to survey scientists who received funding from NIH on what impacts they’ve faced and the results were damning. Health reporters Sarah Rahal and Jonathan Saltzmann explain the results of this survey and what it means for the future of Boston’s biomedical industry.

Learn more about your ad choices. Visit megaphone.fm/adchoices